BTB06584
SIGMA/SML1122 - ≥98% (HPLC)
Synonym: 2-
CAS Number: 219793-45-0
Empirical Formula (Hill Notation): C19H12ClNO6S
Molecular Weight: 417.82
MDL Number: MFCD00103060
Linear Formula: C19H12ClNO6S
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C19H12ClNO6S/c20-14-8- |
| InChI key | WNDWKKPBLAKXMI-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | O=S(C1=CC=C([N+]([O-])=O) |
| solubility | DMSO: 20 mg/mL, clear |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | BTB06584 inhibits the ATP hydrolase activity of mitochondrial F1F0 ATP synthase. |
| Biochem/physiol Actions: | BTB06584 inhibits the ATP hydrolase activity of mitochondrial F1F0 ATP synthase. The compound BTB06584 has no affect on oxygen consumption or mitochondrial membrane potential in HL-1, a mouse cardiac cell line, but blocks ATP consumption and ischemic cell death following inhibition of cellular respiration. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS05 |
| Signal word | Danger |
| Hazard statements | H318 |
| Precautionary statements | P280 - P305 + P351 + P338 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


